KLK3 | Kallikrein-related peptidase 3 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TGM4 | Transglutaminase 4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
KLK2 | Kallikrein-related peptidase 2 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACPP | Acid phosphatase, prostate | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK4 | Kallikrein-related peptidase 4 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
HOXB13 | Homeobox B13 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
SLC45A3 | Solute carrier family 45, member 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Tissue enriched |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
MSMB | Microseminoprotein, beta- | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
STEAP2 | STEAP family member 2, metalloreductase | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
PABPC1L2A | Poly(A) binding protein, cytoplasmic 1-like 2A | Predicted intracellular proteins
| | | | | Group enriched |
NEFH | Neurofilament, heavy polypeptide | Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
UPK3A | Uroplakin 3A | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
TMEM79 | Transmembrane protein 79 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ACOXL | Acyl-CoA oxidase-like | Predicted intracellular proteins
| | | | | Group enriched |
CHRM1 | Cholinergic receptor, muscarinic 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
RDH11 | Retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
RBFOX3 | RNA binding protein, fox-1 homolog (C. elegans) 3 | Predicted intracellular proteins
| | | | | Group enriched |
SIX1 | SIX homeobox 1 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
SLITRK5 | SLIT and NTRK-like family, member 5 | Predicted membrane proteins
| | | | | Group enriched |
SORD | Sorbitol dehydrogenase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ARG2 | Arginase 2 | Cancer-related genes Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Group enriched |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
HOXD13 | Homeobox D13 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
SIX2 | SIX homeobox 2 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ALDH1A3 | Aldehyde dehydrogenase 1 family, member A3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CHRNA1 | Cholinergic receptor, nicotinic, alpha 1 (muscle) | Disease related genes Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
DLK2 | Delta-like 2 homolog (Drosophila) | Predicted membrane proteins
| | | | | Tissue enhanced |
EYA1 | EYA transcriptional coactivator and phosphatase 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
FOLH1 | Folate hydrolase (prostate-specific membrane antigen) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FOXA1 | Forkhead box A1 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GATA2 | GATA binding protein 2 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GCNT2 | Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GDF15 | Growth differentiation factor 15 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HIST1H2AD | Histone cluster 1, H2ad | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2AE | Histone cluster 1, H2ae | Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST1H2BG | Histone cluster 1, H2bg | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
HIST2H2BF | Histone cluster 2, H2bf | Predicted intracellular proteins
| | | | | Tissue enhanced |
ISL1 | ISL LIM homeobox 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
LRRC24 | Leucine rich repeat containing 24 | Predicted membrane proteins
| | | | | Tissue enhanced |
LY6G6D | Lymphocyte antigen 6 complex, locus G6D | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MYF5 | Myogenic factor 5 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
MYH3 | Myosin, heavy chain 3, skeletal muscle, embryonic | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PMEPA1 | Prostate transmembrane protein, androgen induced 1 | Cancer-related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RAB3B | RAB3B, member RAS oncogene family | Predicted intracellular proteins
| | | | | Tissue enhanced |
SELE | Selectin E | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SLC14A1 | Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | Blood group antigen proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |